Companies in the diabetes sector developing innovative solutions and technologies.
Explore 45 recently funded diabetes companies with verified founder contact information and fundraising data.
G.I. Windows is a clinical-stage company developing the first fundamental breakthrough in surgical anastomotic technology.
Orpyx Medical Technologies develops sensor-based technologies and self-monitoring devices in medical and athletic spaces.
DreaMed Diabetes offers AI solutions and personalized support for optimized insulin therapy.
The first effortless continuous molecular tracker unlocking human perfomance
Apollon develops noninvasive continuous glucose monitoring systems.
Hedia is a personal diabetes-assistant, based on artificial intelligence.
The most effective Digital Therapy to reverse metabolic dysfunction based on mobile technology, biosensors, AI and behavioral science.
Vitadio develops software and online tools to help prevent and control diabetes.
Digostics develops a glucose tolerance testing platform to assist users in performing tests at home.
Tribal Diagnostics is a diagnostic lab that provides tests for diabetes, heart disease, substance abuse, COVID, and other diseases.
Remote patient monitoring (RPM) for patients at risk of diabetic foot disease.
Podimetrics is a care management company with the leading solution to help prevent diabetic foot amputations.
Digital Health: FDA-approved algorithms to detect multiple conditions from fundus images.
Steto creates diabetes digital therapies and remote patient monitoring solutions.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Restor Metabolix provides diabetic treatment and metabolic disorder that treats patients through physiologic insulin resensitization.
Sensulin is a diabetes drug discovery company developing a once-a-day glucose-responsive insulin.
CASS Pharmaceuticals is a medical company that provides rapid-acting insulin for diabetic patients.
Eyenuk is a medtech company that develops an artificial intelligence screening tool for risk assessment and disease surveillance.
Glooko provides digital health platforms and data management tools for diabetes care.
The diabetes sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Diabetes companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The diabetes sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 45 diabetes companies tracked in the VCBacked database.
Companies in the diabetes sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting diabetes companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked